top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Bioactive Compounds from Marine-Derived Aspergillus, Penicillium, Talaromyces and Trichoderma Species
Bioactive Compounds from Marine-Derived Aspergillus, Penicillium, Talaromyces and Trichoderma Species
Autore Nicoletti Rosario
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (134 p.)
Soggetto non controllato antibacterial activity
Talaromyces purpurogenus
lapatinib
antibacterial
hydroxypyrrolidine
bis-indolyl benzenoids
penitrem A
cytotoxicities
sesquiterpenoid
secondary metabolites
drug discovery
sponge-associated fungus
candidusin
Penicillium sp. TJ403-1
coumarin
gefitinib
bioactive products
Aspergillaceae
indole-diterpenoids
mangroves
diterpenoid
Penicillium raistrickii
ECD calculations
Talaromyces
marine-derived fungi
BK (Maxi-K) channel
polyketides
EGFR
chromone
aspetritone
Aspergillus
breviane spiroditerpenoid
endophytic fungi
cytotoxic
cytotoxicity
breast cancer
mangrove endophytic fungus
IDH1 inhibitory activity
NMR data calculations
antifungal activity
Aspergillus candidus
diastereomers
TNF-?
sterone
Aspergillus clavatus
HER2
thermo-change strategy
ISBN 3-03897-981-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346857703321
Nicoletti Rosario  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Treatment Strategies and Survival Outcomes in Breast Cancer
Treatment Strategies and Survival Outcomes in Breast Cancer
Autore Cheung Kwok-Leung
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (264 p.)
Soggetto non controllato relative survival
young women
cancer treatment
fulvestrant
lapatinib
tumor biology
antihormone therapy
mastectomy
aromatase inhibitors
chemotherapy
serum biomarker
cyclin E
anthracycline resistance
zero-inflated Poisson regression model
lymph-node ratio
CHEK2
comparative effectiveness
breast-conserving therapy
taxane sensitivity
liquid biopsy
HER2 c-erbB2
colorectal cancer
infiltrating breast cancer
survival
exercise characteristics
lactate dehydrogenase
biomarker
breast cancer survivors
BRCA
disease-free survival
PIK3CA
metastatic breast cancer
cell-free DNA
invasive breast cancer
radiotherapy
Metformin
social well-being
gene expression
contralateral breast cancer
basal-like breast cancer
LMK-235
Src kinase
HER2/neu
LKB1
Older women
LDH
mutation carriers
stage IV
mammography screening
NCDB
cMet
SEER
pertuzumab
physical function
outcome
ribociclib
older patients
geriatric oncology
metastatic
overdiagnosis
next-generation sequencing
abemaciclib
Endocrine therapy
monitoring metastatic breast cancer
breast cancer
circulating tumor cells
Breast Cancer
PALB2
histone deacetylase
prognosis
physical activity
trastuzumab
ductal carcinoma in situ
contralateral prophylactic mastectomy
ERCC1
family history
T-DM1
ATM
advanced breast cancer
incidence
palbociclib
HDAC5 inhibitors
APOBEC3B
ISBN 3-03928-759-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910404084403321
Cheung Kwok-Leung  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui